Get the Stockscreener App
175.61
0.53%
0.92
Pre-market:
175.61
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $175.61, with a volume of 5.10M.
It is up +0.53% in the last 24 hours and up +23.63% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$174.69
Open:
$174.8
24h Volume:
5.10M
Relative Volume:
5.04
Market Cap:
$9.43B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-19.05
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
+30.04%
1M Performance:
+23.63%
6M Performance:
+14.08%
1Y Performance:
-2.63%
1-Day Range:
$174.70
$175.80
1-Week Range:
$129.21
$175.80
52-Week Range:
$125.94
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
175.61 | 9.38B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo CorporationMASI - FinancialContent
Danaher moves to acquire Masimo in $9.9bn deal - Life Sciences Intellectual Property Review
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections - Benzinga
Masimo (MASI) Downgraded by Wells Fargo with Lower Price Target - GuruFocus
Is It Too Late to Chase Masimo Stock on Major Danaher News? - Barchart.com
BofA Withdraws Rating on Masimo (MASI) Following Danaher Acquisi - GuruFocus
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
Danaher buys patient monitoring specialist Masimo in $9.9B deal - Fierce Biotech
Masimo (MASI) climbs 34% on $9.9-billion Danaher merger - MSN
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger - Insider Monkey
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections - Bitget
Danaher to Acquire Masimo in $9.9 Billion Deal to Expand Diagnostics Market - NTD News
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
3 Firms Advise On $9.9B Danaher, Masimo Diagnostics Deal - Law360
Danaher to Buy Masimo for $180 Per Share in All-Cash $9.9 Billion Transaction - PYMNTS.com
Masimo Q4 Earnings Release Signals Market Reaction - StocksToTrade
Masimo (NASDAQ:MASI) Shares Gap UpHere's Why - MarketBeat
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
Market movers: Masimo Corporation, Norwegian Cruise Line Holdings, eToro, Paramount Skydance… - Proactive financial news
MASI Stock Alert: Halper Sadeh LLC is Investigating Whether Masimo Corporation is Obtaining a Fair Price for Its Shareholders - Business Wire
Danaher Corporation to Acquire Masimo Corporation - BOSS Publishing
Irvine’s Masimo selling to Danaher, Beckman Coulter owner, for $9.9 billion - Orange County Register
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI) - PR Newswire
Masimo: Danaher Acquisition Saves The Company From Lackluster Performance (NASDAQ:MASI) - Seeking Alpha
Danaher acquires Masimo for $9.9bn to bolster diagnostics business - Yahoo Finance
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Masimo Corporation( - GuruFocus
Danaher to acquire Masimo for $9.9 billion - The Business Journals
Masimo (MASI) Sees Significant 34% Surge in Stock Price - GuruFocus
Midday Stock Roundup: Masimo Jumps on Takeover News - Orange County Business Journal
Danaher to Acquire Masimo for $9.9B - Orange County Business Journal
Danaher Corporation entered into a definitive agreement to acquire Masimo Corporation from Politan Capital Management, L.P for $9.5 billion. - marketscreener.com
Danaher to buy Masimo for $9.9B - BioWorld MedTech
Masimo’s Financial Results Awaited, Market Braces for Insights - timothysykes.com
Danaher to buy Masimo for $10B - MassDevice
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Masimo (MASI) Shares Jump Over 34% Following Significant Surge - GuruFocus
Danaher snaps up diagnostics firm Masimo for $10bn - Sharecast.com
Danaher (DHR) Stock Slides on $10B Masimo Buyout Announcement - Tokenist
Shares of Masimo, Danaher Moving on Acquisition Buzz - Bitget
Danaher agrees to buy Masimo for $9.9B - Modern Healthcare
Danaher Corporation (DHR) Announces Strategic Merger with Masimo - GuruFocus
Masimo shares jump 34% after Danaher agrees to buy the company for $180 per share in cash - Quiver Quantitative
Danaher Agrees to Buy Medical Tech Firm Masimo for $9.9 Billion - Bloomberg
Masimo jumps over 30% on report of potential $10 billion Danaher takeover - MSN
Masimo Preps for Q-Financal Reveal After Market Hours - StocksToTrade
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot - FinancialContent
Market news - investments.halifax.co.uk
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):